Recent advances in targeted protein degradation research in cancer.

Targeted Protein Degradation (TPD) is an innovative therapeutic approach that harnesses the cell's own systems to eliminate harmful proteins, including those previously deemed "undruggable". With TPD's catalytic efficiency, each agent can repeatedly target and degrade multiple protein copies, setting a new standard in cancer treatment efficacy.

Explore the forefront of cancer therapy with our comprehensive literature review on TPD, featuring cutting-edge research utilizing our advanced no-wash immunoassays. This review delves into the latest publications, showcasing breakthroughs in PROTACs, molecular glue degraders, and other pioneering strategies. Join us as we unveil the potential of TPD in oncology, supported by research and technological innovations.

For research use only. Not for use in diagnostic procedures.